Veys Em
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 11
- Spondyloarthritis Studies and Treatments 9
- Osteoarthritis Treatment and Mechanisms 5
- Systemic Lupus Erythematosus Research 4
- Hematology top 5%
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis 3
- T-cell and B-cell Immunology 3
- Genetics top 10%
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Inflammatory Myopathies and Dermatomyositis 3
- Co-authors
- Herman MielantsDe Vos MGust VerbruggenC CuvelierClaude CuvelierStefan GoemaereDirk ElewautLieve Gyselbrecht
- Cited by
- RheumatologyHematologyImmunology
- Journals
- PubMed (34 papers)
- Partner nations
- Belgium
In The Last Decade
Veys Em
34 papers receiving 845 citations
Peers
Comparison fields: 5 of 76
- Rheumatology 610
- Hematology 156
- Immunology 278
- Genetics 274
- Immunology and Allergy 40
Countries citing papers authored by Veys Em
This map shows the geographic impact of Veys Em's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veys Em with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veys Em more than expected).
Fields of papers citing papers by Veys Em
This network shows the impact of papers produced by Veys Em. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veys Em. The network helps show where Veys Em may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Veys Em, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ. | 1997 | 7 |
| 2 | Influence of interferon-gamma on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. | 1993 | 11 |
| 3 | Osteomyelitis in a patient with a chronically infected arterial graft and longstanding hypertrophic osteoarthropathy of the leg. | 1991 | 6 |
| 4 | Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation. | 1990 | 24 |
| 5 | Klinefelter's syndrome and scleroderma. | 1989 | 7 |
| 6 | Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo. | 1988 | 52 |
| 7 | Repeat ileocolonoscopy in reactive arthritis. | 1987 | 36 |
| 8 | Significance of gut inflammation in the seronegative spondyloarthropathies. | 1987 | 6 |
| 9 | Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study. | 1987 | 9 |
| 10 | Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies. | 1984 | 10 |
| 11 | Peripheral blood T lymphocytes subpopulations in HLA-B7 related rheumatic diseases: ankylosing spondylitis and reactive synovitis. | 1983 | 6 |
| 12 | Evaluation of T cell subsets with monoclonal antibodies in synovial fluid in rheumatoid arthritis. | 1983 | 29 |
| 13 | Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis. | 1982 | 67 |
| 14 | B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. | 1980 | 5 |
| 15 | Influence of an oversulphated heparinoid upon hyaluronate metabolism of the human synovial cell in vivo. | 1980 | 13 |
| 16 | Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells. | 1979 | 43 |
| 17 | Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. | 1978 | 14 |
| 18 | Humoral immunity in osteomyelitis and infectious arthritis. | 1975 | 6 |
| 19 | [A study of the loss of occult blood by the method of radioactive chrome during treatment with acetylsalicylic acid. Effect of enclosure in cellulose acetylphthalate]. | 1975 | 3 |
| 20 | Total activity and isoenzyme patterns of lactate dehydrogenase in synovial fluid. | 1970 | 2 |
About Veys Em
Veys Em is a scholar working on Rheumatology, Complementary and Manual Therapy, Immunology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 34 papers that have together received 913 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (11 papers), Spondyloarthritis Studies and Treatments (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Systemic Lupus Erythematosus Research (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Rheumatology (610 citations), Hematology (156 citations), Immunology (278 citations), Genetics (274 citations) and Immunology and Allergy (40 citations). Veys Em has collaborated with scholars based in Belgium. Frequent co-authors include Herman Mielants, De Vos M, Gust Verbruggen, C Cuvelier, Claude Cuvelier, Stefan Goemaere, Dirk Elewaut, Lieve Gyselbrecht, L Schatteman and Gideon Goldstein. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.